PMID: 16626005Apr 22, 2006Paper

Lowering cholesterol in the elderly--yes, no, or maybe?

MMW Fortschritte der Medizin
M Gogol

Abstract

At the present time, there is no adequate database for the application of statins for cholesterol lowering in geriatric patients. According to the current position adopted by the IOWiG (Institut für Qualität and Wirtschaftlichkeit im Gesundheitswesen = institute for quality and economy in health care), the usefulness of statins in patients with stable CAD or acute coronary syndrome can be affirmed. The National Institute of Clinical Excellence favors the administration of statins both in primary and secondary prevention of CAD and myocardial infarction, and also as a secondary prevention measure in non-severe stroke, PAD, unstable angina pectoris, and following revascularization procedures on the coronary arteries. Evidence for the superiority of the statins in patients older than 75 is, to date, available only for the indication of CAD in patients with elevated LDL cholesterol, but only up to the age of 80 years. Secondary prevention with statins leading to multipharmacotherapy must be rejected on account of the incalculable risk of side effects and drug interactions.

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

BMC Health Services Research
Franz PorzsoltVolker Amelung
GMS health technology assessment
Annette ZentnerReinhard Busse
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
A SchwalmA Gerber
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung
Hilda BastianSindy Matschewsky
© 2022 Meta ULC. All rights reserved